INNOVADERM CRO IS NOW INDERO.

Building Momentum in Clinical Trial Start‑Up

Delays in site start‑up remain one of the biggest obstacles to efficient clinical trial delivery, often caused by lengthy feasibility processes, protracted contract negotiations and poor communication between stakeholders. This International Clinical Trials article, written by Esther Sanchez, Associate Director, Start-Up at Indero, highlights practical insights on how to overcome these challenges through data‑driven site […]

Episode 39: Esther Sanchez – Building a Robust Startup Unit in Clinical Trials

Innovaderm to Indero

ï»ż   In this episode, Esther SĂĄnchez, Associate Director of the Global Start-Up Unit at Indero, brings more than 24 years of experience in clinical research to our discussion. Esther provides expert perspective on the vital role of a strong startup team in clinical trials, shares the key factors that contribute to team effectiveness, and highlights strategies […]

What Sites Look for in Sponsors: A Practical Checklist

The relationship between sponsors and investigative sites is more critical than ever. Sites are not just service providers, they are essential partners in delivering high-quality, efficient, and ethical clinical trials. Yet, many sponsors and CROs fall short in meeting site expectations, leading to operational inefficiencies, diminished motivation, and even site attrition.   Contributing their expert insights […]

A Site-Centric Approach to Protocol Usability

Protocol usability is a critical yet often overlooked factor in clinical trial efficiency. Errors and inconsistencies within protocols and supporting documents can lead to confusion, operational delays, and protocol deviations at research sites. This article explores how a site-centric approach emphasizing clarity, integration, and operational feasibility can significantly reduce these issues and enhance trial execution. […]

Successful Clinical Trial Site Management: A Guide for Biotech and Pharmaceutical Sponsors

Indero’s progression from a small research site to a global CRO illustrates the pivotal role that robust infrastructure plays in clinical research. Drawing on its experienced team and broad network, Indero is able to efficiently assess the capabilities of potential clinical trial sites, including evaluating investigator motivation and local resources. This thorough and systematic approach helps sponsors identify high-performing sites well-suited […]

Delayed Payments, Diminished Performance: The Site Perspective

Delayed Payments, Diminished Performance

Delayed payments and financial holdbacks from sponsors and CROs are placing increasing strain on clinical trial sites, threatening their operational stability and performance. Contributing their expert insights are Ted Trafford, a veteran executive who has spent nearly 30 years at Probity Medical Research building a global network of over 70 investigative sites across multiple therapeutic areas, and Brad […]

Strengthening Sponsor–Site Partnerships in Clinical Research: Keys to Sustained Site Motivation and Operational Success

Sponsor–Site Partnerships in Clinical Research

Successful collaboration between sponsors, CROs, and clinical trial sites is a cornerstone of efficient and high-quality clinical research. This article explores the key dos and don’ts for fostering productive site partnerships, with a focus on sustaining investigator motivation and study momentum. Contributing their expert insights are Ted Trafford, a veteran executive who has spent nearly 30 […]

Accelerating Study Start-Up and Contract Negotiations in Clinical Trials: A Guide for Biotech and Pharmaceutical Sponsors

The efficiency of study start-up and contract negotiations can significantly impact the success of clinical trials. Streamlining these processes ensures that trials commence on time and run smoothly. This article explores best practices for accelerating study start-up and contract negotiations, with a focus on what biotech, and pharmaceutical companies need to know.  Streamlining Contract Negotiations  […]

Laying the Foundation: Mastering Site Selection for Effective Clinical Studies

clinical trial site selection process

Site selection is a foundational element in the success of a trial, akin to laying the groundwork for a stable and enduring structure. Understanding the nuances of site selection, including the importance of a dynamic site database and the evolution of site performance, is essential for contract research organizations (CROs) aiming to conduct effective and […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.